The Australian College of Pharmacy has made a formal TGA submission in support of an application by Bayer to reschedule erectile dysfunction medication vardenafil to S3.
"We believe that pharmacists are eminently capable to assess patients for their suitability for vardenafil or to refer them to a doctor if further investigation is required," the college said, having produced a training module and protocol used to support the Bayer application.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Sep 16
